 |
|
 |
|
|
|
| CellTran. Specialists in wound healing innovation.
We are working to provide new solutions to problem wounds. CellTran produce myskin using autologous skin cells. Keratinocyte cells from the patient’s dermis and epidermis cells grow on an advanced polymer layer from which they are applied directly to the site of wound healing. CellTran also operates a skin bank through which we can assist clinics and surgical units in the storage and provision of autologous graft skin. |
|
||
|
|
|
|
|
||
 |
Myskin is the first product to be launched by CellTran for the active treatment of difficult to heal wounds. This is ground-breaking treatment which offers ease of use for the benefit of both patient and medical professional. Click to read more about myskin | ||
|
|||
|
|
||
|
|||
 |
The myskin Clinic is a private treatment centre dedicated to the treatment of chronic, complex or non-healing wounds. Click to visit the myskin Clinic site | ||
 |
|
|
20/08/07 CellTran successfully completes £1M fund raising round. View press release (pdf) 07/08/07 CellTran technology featured at "Designs of the Time '07" Exhibition. Read more 12/03/07 CellTran commision new clean room facility. Read more 02/10/06 Celltran and XCELLentis successfully complete merger. View press release (pdf) 20/07/06 CellTran and Innogenetics enter into exclusive negotiations to combine CellTran and XCELLentis wound care activities. View press release (pdf) 20/09/05 John Healey MP visits CellTran's labs and facilities. Read more 10/08/05 Celltran receive MHRA accreditation. View press release |
|
|
CellTran |
|